Cargando…

Reduced Interaction of Aggregated α-Synuclein and VAMP2 by Environmental Enrichment Alleviates Hyperactivity and Anxiety in a Model of Parkinson’s Disease

Parkinson’s disease (PD) is a prevalent motor disease caused by the accumulation of mutated α-synuclein (α-Syn); however, its early stages are also characterized by non-motor symptoms, such as olfactory loss, cognitive decline, depression, and anxiety. The therapeutic effects of environmental enrich...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kyungri, Wi, Soohyun, Seo, Jung Hwa, Pyo, Soonil, Cho, Sung-Rae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998569/ https://www.ncbi.nlm.nih.gov/pubmed/33801790 http://dx.doi.org/10.3390/genes12030392

Ejemplares similares

Environmental Enrichment Attenuates Oxidative Stress and Alters Detoxifying Enzymes in an A53T α-Synuclein Transgenic Mouse Model of Parkinson’s Disease
por: Seo, Jung Hwa, et al.
Publicado: (2020)

Environmental Enrichment and Estrogen Upregulate Beta-Hydroxybutyrate Underlying Functional Improvement
por: Pyo, Soonil, et al.
Publicado: (2022)

Reelin Alleviates Mesenchymal Stem Cell Senescence and Reduces Pathological α-Synuclein Expression in an In Vitro Model of Parkinson’s Disease
por: Cho, Eunju, et al.
Publicado: (2021)

The Effect of Environmental Enrichment on Glutathione-Mediated Xenobiotic Metabolism and Antioxidation in Normal Adult Mice
por: Seo, Jung Hwa, et al.
Publicado: (2018)

An Enriched Environment Ameliorates Oxidative Stress and Olfactory Dysfunction in Parkinson’s Disease with α-Synucleinopathy
por: Wi, Soohyun, et al.
Publicado: (2018)

Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling
por: Sun, Jichao, et al.
Publicado: (2019)

Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
por: George, Sonia, et al.
Publicado: (2015)

Vamps & tramps /
por: Paglia, Camille, 1947-
Publicado: (2001)

Lovastatin Alleviates α-Synuclein Aggregation and Phosphorylation in Cellular Models of Synucleinopathy
por: Dai, Lijun, et al.
Publicado: (2021)

Association of VAMP-2 and Syntaxin 1A Genes with Adult Attention Deficit Hyperactivity Disorder
por: Kenar, Aẙe Nur Inci, et al.
Publicado: (2014)

Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
por: Tatenhorst, Lars, et al.
Publicado: (2016)

Environmental Enrichment Enhances Ca(v) 2.1 Channel-Mediated Presynaptic Plasticity in Hypoxic–Ischemic Encephalopathy
por: Song, Suk-Young, et al.
Publicado: (2021)

The Longin SNARE VAMP7/TI-VAMP Adopts a Closed Conformation
por: Vivona, Sandro, et al.
Publicado: (2010)

Cervical skin denervation associates with alpha‐synuclein aggregates in Parkinson disease
por: Melli, Giorgia, et al.
Publicado: (2018)

Parkinson’s Disease: A Nanotheranostic Approach Targeting Alpha-Synuclein Aggregation
por: Zoey, Fong LaiGuan, et al.
Publicado: (2021)

Silica Nanoparticles Promote α-Synuclein Aggregation and Parkinson’s Disease Pathology
por: Yuan, Xin, et al.
Publicado: (2022)

Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease
por: Emin, Derya, et al.
Publicado: (2022)

Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
por: Lee, Jihoon, et al.
Publicado: (2023)

Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2
por: Diao, Jiajie, et al.
Publicado: (2013)

Factors affecting cognition and emotion in patients with traumatic brain injury
por: Kwak, Eun Hee, et al.
Publicado: (2020)

Arabidopsis R-SNARE Proteins VAMP721 and VAMP722 Are Required for Cell Plate Formation
por: Zhang, Liang, et al.
Publicado: (2011)

The binding of Varp to VAMP7 traps VAMP7 in a closed, fusogenically inactive conformation
por: Schäfer, Ingmar B., et al.
Publicado: (2012)

The Role of Alpha-Synuclein Oligomerization and Aggregation in Cellular and Animal Models of Parkinson’s Disease
por: Wan, Oi Wan, et al.
Publicado: (2012)

Catecholamines and Neurodegeneration in Parkinson’s Disease—From Diagnostic Marker to Aggregations of α-Synuclein
por: Sawada, Hideyuki, et al.
Publicado: (2013)

Blood Plasma of Patients with Parkinson's Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity
por: Wang, Peng, et al.
Publicado: (2016)

Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models
por: Javed, Hayate, et al.
Publicado: (2019)

Differential Aggregation and Phosphorylation of Alpha Synuclein in Membrane Compartments Associated With Parkinson Disease
por: Canerina-Amaro, Ana, et al.
Publicado: (2019)

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage
por: Majbour, Nour, et al.
Publicado: (2022)

Dynamics of a model for the degradation mechanism of aggregated α-synuclein in Parkinson's disease
por: Yang, Bojie, et al.
Publicado: (2023)

Correction: Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
por: Lee, Jihoon, et al.
Publicado: (2023)

Anionic Nanoplastic Contaminants Promote Parkinson’s Disease-Associated α-Synuclein Aggregation
por: Liu, Zhiyong, et al.
Publicado: (2023)

Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation
por: Liu, Zhiyong, et al.
Publicado: (2023)

Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease
por: Brown, Emmeline E., et al.
Publicado: (2021)

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
por: Schulz-Schaeffer, Walter J.
Publicado: (2010)

Fusogenic Pairings of Vesicle-Associated Membrane Proteins (VAMPs) and Plasma Membrane t-SNAREs – VAMP5 as the Exception
por: Hasan, Nazarul, et al.
Publicado: (2010)

The Aggregation of Huntingtin and α-Synuclein
por: Chánez-Cárdenas, María Elena, et al.
Publicado: (2012)

Monitoring α-synuclein aggregation
por: Estaun-Panzano, Juan, et al.
Publicado: (2023)

New Roles of Glycosaminoglycans in α-Synuclein Aggregation in a Cellular Model of Parkinson Disease
por: Lehri-Boufala, Sonia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3hlb8c1vem037fjh14c3bhilvk